Back to Search
DAVID MATTHEWS, MD
MD
Infectious Disease Physician
NPI: 1831261304Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
5711173-1205(UT)
Research & Publications (20)
Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo.
PMID 17245119·Cell Cycle·2007
4-observational
Using model-system genetics for drug-based target discovery.
PMID 11165187·Drug Discov Today·2001
8-other
The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress.
PMID 19455309·Psychopharmacology (Berl)·2009
6-review
Glycaemic risk assessment in children and young people with Type 1 diabetes mellitus.
PMID 19573125·Diabet Med·2009
8-other
Vitamin B-6 restriction tends to reduce the red blood cell glutathione synthesis rate without affecting red blood cell or plasma glutathione concentrations in healthy men and women.
PMID 19515736·Am J Clin Nutr·2009
8-other
An analysis of major UK newspaper articles pertaining to 'diabetes' and 'cure' over 1 year.
PMID 19388979·Diabet Med·2009
8-other
Nitrate and bisulfide: monitoring and patterns in Onondaga Lake, New York, following implementation of nitrification treatment.
PMID 19472938·Water Environ Res·2009
8-other
Correlation between the Oxford Knee and American Knee Society scores at mid-term follow-up.
PMID 19634726·J Knee Surg·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3590 W 9000 S, SUITE 240
WEST JORDAN, UT 84088 - Phone
- (801) 569-2384
Quick Facts
- NPI
- 1831261304
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile